Home
About
Publications Trends
Recent Publications
Expert Search
Archive
cranial nerve palsies
What are the Symptoms of Cranial Nerve Palsies in Cancer Patients?
The symptoms depend on which cranial nerve is affected:
Olfactory Nerve (I)
: Loss of smell
Optic Nerve (II)
: Visual disturbances
Oculomotor Nerve (III)
,
Trochlear Nerve (IV)
,
Abducens Nerve (VI)
: Double vision, difficulty moving the eye
Trigeminal Nerve (V)
: Facial pain, loss of facial sensation
Facial Nerve (VII)
: Facial muscle weakness, loss of taste
Vestibulocochlear Nerve (VIII)
: Hearing loss, balance issues
Glossopharyngeal Nerve (IX)
,
Vagus Nerve (X)
: Difficulty swallowing, loss of gag reflex
Accessory Nerve (XI)
: Shoulder weakness
Hypoglossal Nerve (XII)
: Tongue weakness
Frequently asked queries:
What are Cranial Nerve Palsies?
How Can Cancer Cause Cranial Nerve Palsies?
Which Cancers are Most Commonly Associated with Cranial Nerve Palsies?
What are the Symptoms of Cranial Nerve Palsies in Cancer Patients?
How are Cranial Nerve Palsies Diagnosed in Cancer Patients?
What are the Treatment Options for Cranial Nerve Palsies in Cancer Patients?
What is the Prognosis for Cancer Patients with Cranial Nerve Palsies?
How Can Google Cloud AI Assist in Cancer Research?
What is Hemodynamic Monitoring?
How Does Cancer Cause Mobility Issues?
What is the Prognosis for Physical Limitations?
What are the Mechanisms of Tumor Resistance to ADCC?
What is the Role of Artificial Intelligence in Enhancing IoMT for Cancer Care?
What are the Advantages of Y2H Screening?
What Role Does Technology Play in Delivery?
What Role Does CoC Play in Education and Advocacy?
How Does Cancer Lead to Hepatic Impairment?
How Does Hormesis Affect Cancer Therapy?
How Can Women Participate in WHI Studies?
Can Liquid Biopsies Detect DNA Changes in Cancer?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Nanotechnology
Non-Hodgkin’s Lymphoma
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
CIAbimatoprost
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
diffuse large B-cell lymphoma
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
Keratinocyte
Lipid-based nanoparticles
liver cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
radiotherapy
refractory lymphoma
relapsed lymphoma
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe